XML 112 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
Convertible Debt - Additional Information (Detail) (USD $)
0 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 1 Months Ended 12 Months Ended
Jan. 09, 2012
Nov. 30, 2006
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Interest Rate Swap
Dec. 31, 2010
Interest Rate Swap
Dec. 31, 2011
Convertible Senior Notes 2013
Nov. 30, 2006
Purchased Options
Dec. 31, 2011
Purchased Options
Dec. 31, 2011
Purchased Options
Dec. 31, 2011
Purchased Options
Group 1
Dec. 31, 2011
Purchased Options
Group 2
Nov. 30, 2006
Sold Warrants
Dec. 31, 2011
Sold Warrants
Issuance date   11/1/2006                          
Proceed from issuance of senior unsecured obligations   $ 3,450,000,000                          
Debt instrument, convertible, terms of conversion feature     (1) during the five business-day period after any five consecutive trading-day period (the “measurement period”) in which the price per Note for each day of that measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such day; (2) during any calendar quarter, if the last reported sale price of our common stock for 20 or more trading days in a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter exceeds 130% of the applicable conversion price in effect on the last trading day of the immediately preceding calendar quarter; or (3) upon the occurrence of certain events specified in the Notes. Additionally, the 2013 Notes will become convertible during the last three months prior to their maturity.                        
Shares of our common stock converted per one thousand dollars of principal amount of Notes   62.1978                          
Conversion premium   27.50%                          
Conversion price   $ 16.08                          
Conversion premium based on the closing price   55.00%                          
Closing price per share   $ 12.61                          
Convertible debt, carrying amount               1,724,500,000              
Convertible debt, fair value               2,500,500,000              
Carrying amount of the equity component               263,500,000              
Semi annual Interest rate     1.75%                        
Debt Instrument, frequency of periodic payment     Semi-annually                        
Debt Instrument, unamortized discount               119,300,000              
Debt amortization period     will be fully amortized by December 31, 2013.                        
Effective interest rate     5.60% 5.60% 5.60%                    
Common stock at an exercise price                           $ 19.55  
Proceeds from the sale of the warrants                           391,100,000  
Aggregate amount paid for purchased options     140,993,000 0 0       669,100,000            
Cash payment to noteholders for outstanding principle of converted Notes 1,699,800,000                            
Shares issued to noteholders for the excess of the conversion value over the principle amount of converted Notes 29,500,000                            
Value of the conversion value over the principle amount of converted Notes 661,400,000                            
Converted Notes               500,000              
Purchased Options Exercised                       107,500,000      
Purchased Options Shares Received                   29,500,000          
Purchased Options Expiration                         107,500,000    
Description of derivative transaction associated with convertible debt                     In connection with the issuance of the Notes, we entered into separate convertible note hedge transactions with respect to our common stock (the “Purchased Options”). The Purchased Options allow us to receive shares of our common stock and/or cash related to the excess conversion value that we would pay to the holders of the Notes upon conversion. The Purchased Options will cover, subject to customary anti-dilution adjustments, approximately 215 million shares of our common stock.       We also entered into separate transactions in which we sold warrants to acquire, subject to customary anti-dilution adjustments, approximately 215 million shares of our common stock at an exercise price of approximately $19.55 per share of our common stock. Half of the associated warrants have expiration dates between February 15, 2012 and March 14, 2012 and the remaining half of the associated warrants have expiration dates between February 18, 2014 and March 18, 2014.
Notional amount of cash flow hedges             900,000,000                
Realized loss on replaced interest rate swap contracts           $ 141,000,000